Rota Virus Diarrhea Vaccines

DrugDrug NameDrug Indication
DB10276Rotavirus VaccineRotarix is indicated for prevention of rotavirus gastroenteritis caused by G1, G3, G4, and G9 types in infants aged 6-24 weeks [FDA Label]. Rotateq is indicated for the prevention of rotavirus gastroenteritis caused by G1, G2, G3, G4, and G9 types in infants aged 6-32 weeks [L1116].
DrugDrug NameTargetType